共 138 条
[1]
Katz LY(2008)Effect of regulatory warnings on antidepressant prescription rates, use of health services and outcomes among children, adolescents and young adults. [Erratum appears in CMAJ. 2008 May 20;178(11):1466] CMAJ 178 1005-1011
[2]
Kozyrskyj AL(2009)Decreased use of antidepressants in youth after US Food and Drug Administration black box warning Psychiatry (Edgmont) 6 30-34
[3]
Prior HJ(2007)Early evidence on the effects of regulators’ suicidality warnings on SSRI prescriptions and suicide in children and adolescents Am J Psychiatry 164 1356-1363
[4]
Enns MW(2008)Antidepressant prescribing practices for the treatment of children and adolescents J Child Adolesc Psychopharmacol 18 70-80
[5]
Cox BJ(2007)Effect of regulatory warnings on antidepressant prescribing for children and adolescents Arch Pediatr Adolesc Med 161 690-696
[6]
Sareen J(2010)Patterns of antidepressant use in Quebec children and adolescents: trends and predictors Psychiatry Res 179 57-63
[7]
Singh T(2007)Decline in treatment of pediatric depression after FDA advisory on risk of suicidality with SSRIs Am J Psychiatry 164 884-891
[8]
Prakash A(2008)Effects of Food and Drug Administration warnings on antidepressant use in a national sample Arch Gen Psychiatry 65 94-101
[9]
Rais T(2009)Persisting decline in depression treatment after FDA warnings Arch Gen Psychiatry 66 633-639
[10]
Kumari N(2007)The effect of antidepressant warnings on prescribing trends in Ontario, Canada Am J Public Health 97 750-754